Navigation Links
Online Voting Begins for Ford Customer Service Division's Second Annual Funny Car Design Contest to Support Juvenile Diabetes Research Foundation
Date:7/2/2009

, a six-year-old resident of Greenville, Texas, and member of the Greater Dallas Chapter of the Juvenile Diabetes Research Foundation. Millard and his family were special guests at the NHRA U.S. Nationals in Indianapolis where his design appeared on Tasca's Ford Shelby Mustang Nitro Funny Car. Last year's contest drew 306 designs and help raise awareness and more than $84,000 for JDRF.

Diabetes affects more Ford families than any other disease. Ford Motor Company has raised more than $27 million for JDRF since the grassroots campaign started in 1998.

About Juvenile Diabetes Research Foundation (JDRF)

JDRF is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is a disease, which strikes children suddenly and requires multiple injections of insulin daily or a continuous infusion of insulin through a pump. Insulin, however, is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.

Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.3 billion to diabetes research, including more than $156 million in FY2008. In FY2008, the Foundation funded 1,000 centers, grants and fellowships in 22 countries. http://www.jdrf.org

About Motorcraft

Motorcraft(R) offers a complete line of original equipment-approved parts that are recommended and approved by Ford Motor Company. From routine maintenance to underhood and powertrain repairs, Motorcraft parts offer exceptional value with the highest quality and right fit at competitive prices. Motorcraft parts a
'/>"/>

SOURCE Ford Motor Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. HIV denialists spread misinformation online -- consequences could be deadly; and more
2. Consequences of online HIV denial; and more
3. Online Epidemic Gives Clues to Bird Flu Spread
4. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
5. Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding
6. Syndicom to Launch Online Community for DePuy Spine
7. Elder Caregiving Site ShirleyBOARD.com Wins WebAward for Outstanding Online Community
8. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
9. CIGNA Behavioral Health Offers Members Online Provider Profiles
10. Dynamic Energy Systems Goes Online and On-Demand
11. North Shore-LIJ Health System Begins Online Posting of Hospital Infection Rates, Other Performance Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... (PRWEB) November 26, 2014 The city ... water shortages, is moving forward with a plan to ... water.* Radio host Sharon Kleyne supports the San Diego ... Water Management” (TWM). According to Kleyne, by recycling water ... import new water could be greatly reduced. (Spagat, E, ...
(Date:11/26/2014)... 2014 GI for Life announced today, ... in prices of their popular nutritional supplements: ColoVite ... . Discounts of 40% will be offered for ... Life’s proprietary ColoVite supplement is a scientifically formulated vitamin ... health. One easy-to-take colon vitamin with ALL the nutrients ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Call 866-997-4948 ... requirements or email the details on sales(at)researchmoz(dot)us , ... and drug discovery market 2014" with deep study of ... the result of high blood sugar. The global glucose ... linked to the growing number of diabetics in the ...
(Date:11/26/2014)... News Facts , Lexmark’s ... RSNA 2014 in Chicago. The company will demonstrate ... images, photos, videos and documents found throughout the ... learn more about these innovative medical content management ... initiatives – that enable more informed clinical decisions, ...
(Date:11/26/2014)... TUESDAY, Nov. 25, 2014 (HealthDay News) -- Teens ... likely to abuse those drugs than other teens, ... the need to conduct substance abuse assessments on ... researchers said. "Prescribers and parents don,t realize ... a professor at the University of Michigan School ...
Breaking Medicine News(10 mins):Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2
... found a way to curb hunger, rev up energy ... of a brain enzyme may curb appetite and boost ... a new study. , Prolylcarboxypeptidase (PRCP) regulates the ... hunger while revving up the body,s energy levels. If ...
... , The National Comprehensive Cancer Network ... the Comparative Effectiveness of health care technologies in cancer care. This ... Effectiveness in Cancer Care to be held in December 2009 , ... The National Comprehensive Cancer Network (NCCN) ...
... , , , , ... Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL), ... innovation today announced a research and development collaboration agreement with nationally ... Research Institute LLC in Tamarac, FL. The partnership will allow Dr. ...
... , , RONKONKOMA, N.Y., July 22 NBTY, ... a leading global manufacturer and marketer of nutritional supplements, today announced ... the United Kingdom by the provisional findings of the Competition Commission. ... on or before September 3, 2009. , , ...
... , BOSTON, July 22 Don,t want a mediocre funeral ... Boston area options. , , "There are people ... even know they have a choice about how to proceed. You can educate ... to the fastest place they can, a funeral home. The funeral homes, though, ...
... ... announced today the formation of their Dentistry Council of Advisors (DCA). The DCA will include ... will help shape the direction of Dentra solutions to dental practices, labs, schools, manufacturers and ... satisfaction. , ...
Cached Medicine News:Health News:NCCN Will Convene National Policy Summit on Comparative Effectiveness in Cancer Care 2Health News:NCCN Will Convene National Policy Summit on Comparative Effectiveness in Cancer Care 3Health News:Cryo-Cell Announces C'elle(SM) Research and Development Collaboration for Chronic Wound Healing Management 2Health News:Cryo-Cell Announces C'elle(SM) Research and Development Collaboration for Chronic Wound Healing Management 3Health News:Cryo-Cell Announces C'elle(SM) Research and Development Collaboration for Chronic Wound Healing Management 4Health News:Cryo-Cell Announces C'elle(SM) Research and Development Collaboration for Chronic Wound Healing Management 5Health News:NBTY Acquisition of Julian Graves Unconditionally Cleared 2Health News:NBTY Acquisition of Julian Graves Unconditionally Cleared 3Health News:NBTY Acquisition of Julian Graves Unconditionally Cleared 4Health News:NBTY Acquisition of Julian Graves Unconditionally Cleared 5Health News:The Boston Funeral Guide Is 'Live' 2Health News:Dentra™ Announces Dentistry Council of Advisors 2Health News:Dentra™ Announces Dentistry Council of Advisors 3
(Date:11/26/2014)... Colo. , Nov. 25, 2014 /PRNewswire/ ... ) today announced that its Chief Executive ... at the following upcoming conferences.  The public ... through webcasts on the Array BioPharma website:  ... December 3, 2014Time:1:30 p.m.  Eastern Time Location: ...
(Date:11/26/2014)... OAKS, Calif. and LONDON , ... ) and AstraZeneca (NYSE: AZN ) today announced ... evaluating two doses of brodalumab in more than 1,800 patients ... with both Stelara ® (ustekinumab) and placebo at week ... brodalumab weight-based analysis group were each shown to be superior ...
(Date:11/26/2014)... and HERZLIYA PITUACH, Israel, Nov. 25, 2014 ... or "the Company"), a clinical stage biopharmaceutical company ... targeted therapeutics for the treatment of inflammatory diseases ... previously announced underwritten public offering of 3,450,000 units, ... the Company,s common stock, par value $0.0001 per ...
Breaking Medicine Technology:Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5
... successful,KB2115 Phase II study meets primary objectives. The ... KB2115 in patients with dyslipidemia,has been successfully completed. ... respect to a broad range of parameters,reflecting effects ... thyroid hormone receptor (TR) is a key regulator ...
... the Congress of the European Hematology,Association, SAN ... , a biopharmaceutical company developing patient-specific,active immunotherapies ... from a Phase 2 clinical trial of ... (NHL). The data were,reported at the Congress ...
Cached Medicine Technology:Karo Bio Announces Sucessfule Phase II Results of KB2115 2Karo Bio Announces Sucessfule Phase II Results of KB2115 3Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 2Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 3
... providers can code the charge while completing a ... while away from office, both directly feeding the ... an Encounter Form/Superbill, data entry can be done ... patient payments are posted by reflecting open item ...
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....
... features 4 precisely angled 64° mirrors to ... anterior chamber angle with slight rotation. ... element) provides a stable platform during laser ... mirror lens provides a complete view of ...
Medicine Products: